Content Type: Article

  • This Is Not a Drill: Hospital and Health System Preparedness for COVID-19

    This Is Not a Drill: Hospital and Health System Preparedness for COVID-19

    ARTICLE / CLIENT ALERT

    This Is Not a Drill: Hospital and Health System Preparedness for COVID-19

    March 2, 2020

    Read time: 5 min

    Key takeaways
    Overview

    As more cases emerge highlighting the transmission of COVID-19 from person-to-person contact in the general public rather than through contact with a known infected individual, hospitals and health systems must be ready to move from emergency preparedness tabletop drills to the real thing. We provide a list of recommendations and resources for hospitals and health systems as they marshal their resources to address COVID-19 from the front lines.

    In depth

    As more cases emerge highlighting the transmission of COVID-19 from person-to-person contact in the general public rather than through contact with a known infected individual, hospitals and health systems must be ready to move from emergency preparedness tabletop drills to the real thing. If projections are correct, COVID-19 infections will soon be a fact of life across the United States.

    A few reminders and suggestions for hospitals and health systems as they marshal their resources:

    • Take those emergency preparedness plans, policies and procedures off the shelf. Since 2017, the Centers for Medicare and Medicaid Services (CMS) has required Medicare and Medicaid enrolled providers and suppliers, including hospitals, to develop, update and drill on emergency preparedness measures. Providers should focus on assessing “all hazards” to determine the processes necessary to meet the health, safety and security needs of the facility, staff, patients and the general community (see Appendix Z of the CMS State Operations Manual for details). The Joint Commission and other accrediting organizations have similar requirements.
      • In 2019, CMS expanded the guidance for assessing “all hazards” to include emerging infectious diseases in addition to other emergencies and disasters. If hospitals have failed to fully evaluate emerging infectious disease as part of “all hazards,” now is the time to ensure that plans clearly document the management of such hazards.
      • If a hospital has not undertaken tabletop drills or other preparatory activities, now is the time to do so, to better understand gaps and vulnerabilities, and plan how to address them.
    • Hospitals should closely track current guidance on COVID-19. Centers for Disease Control and Prevention (CDC) guidance is updated as the agency learns more about the virus and its spread, and provides additional preparedness resources, including checklists and tools specific to hospitals and healthcare professionals. State health departments may have similar guidance with state-specific information.
      • Click here for the CDC Hospital Preparedness Checklist.
      • Click here for the CDC Healthcare Professional Preparedness Checklist.
    • Regardless of size, hospitals must be prepared to screen, stabilize and treat, or appropriately transfer patients who present with symptoms and a history that suggest potential COVID-19 infection. The Emergency Medical Treatment and Labor Act (EMTALA) continues to apply to all Medicare-participating hospitals with emergency departments.
    • Hospitals and other healthcare providers should immediately notify their local or state health department upon identification of a “person under investigation” for infection with COVID-19. As of the date of this publication, local or state health departments must give approval before facilities and providers may submit samples for testing and confirmation.
    • Section 1135 waivers are not yet an option for facilities caring for patients infected with or suspected of having COVID-19, because as of the date of this publication, the president has not declared a disaster or emergency under the Stafford Act or National Emergencies Act. While the US Department of Health and Human Services has declared a public health emergency in relation to COVID-19, a presidential declaration must also be in place for Section 1135 waivers to be implemented. The CMS Conditions of Participation for Hospitals (COPs), EMTALA and other operating requirements thus remain firmly in place for Medicare-participating hospitals.
      • Facilities facing challenges complying with COPs and other requirements can request accommodations from CMS, and should communicate with their state department of health and CMS regional office to discuss their specific facts and any requested accommodations.
      • If a Section 1135 waiver is authorized, the process for taking advantage of the waiver will likely include submission of requests to the state department of health or CMS regional office, with information on the specific facts that require reliance on the waiver. Based on prior waiver events, CMS and/or the state department of health will review the request and decide on a case-by-case basis whether the provider may operate under the waiver.
      • Waivers and any other accommodations are typically approved on a time-and-circumstances-limited basis, and only to the extent that the provider has been affected by the emergency. This means that hospitals and other providers not directly affected by the emergency will not be eligible to operate under the waiver unless it is a “blanket” waiver applicable to all providers in an identified area.

    COVID-19 may also have employment-related effects on hospitals and health systems. Consider exposure plans, staff testing requirements and occupational health needs, and identification of essential and backup staff.

    Authors

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • The Regulatory Framework for Shareholder Loans from Real Estate Funds to Property Companies – And Vice Versa

    ARTICLE

    The Regulatory Framework for Shareholder Loans from Real Estate Funds to Property Companies – And Vice Versa

    March 2, 2020

    Read time: 2 min

    Key takeaways
    Overview

    When structuring real estate transactions for real estate funds, it can be advantageous to issue shareholder loans by the fund to a property company (“downstream loan”). Similarly, there may be situations in which it is economically advisable to grant loans from a property company to a fund (“upstream loan”). In both cases, the question arises as to whether these measures are permissible under supervisory law.

    Read the full article in German here.

    In depth
    Authors

    Frank Müller

    Partner

    Frankfurt

    More insights

  • New ESG Disclosure Obligations to Take Effect in March 2021

    New ESG Disclosure Obligations to Take Effect in March 2021

    ARTICLE / CLIENT ALERT

    New ESG Disclosure Obligations to Take Effect in March 2021

    March 2, 2020

    Read time: 6 min

    Key takeaways
    Overview

    The EU regulation on Sustainability-Related Disclosures (“Disclosure Regulation”)[1] will take effect on March 10, 2021. Its aim is to enhance transparency regarding integration of environmental, social and governance matters (“ESG”) into investment decisions and recommendations. Many of the requirements of the Disclosure Regulation will apply to investment managers that do not focus on ESG mandates.

    The Disclosure Regulation forms part of a package of legislative initiatives designed to promote the engagement of financial services providers in building a sustainable economy of the future. These legislative initiatives also include the draft Taxonomy Regulation[2] which establishes a framework for classifying financial products as “sustainable investments” — a measure directed at tackling so-called “greenwashing” of financial products. Other elements of the package include proposed amendments to MiFID II[3], AIFMD and UCITS[4] that will require asset managers to integrate ESG considerations into their organisational and operational controls, and risk management processes.

    Key Requirements

    The Disclosure Regulation will require AIFMs, UCITS management companies, as well as portfolio managers and investment advisers authorised under MiFID, to implement policies and make certain disclosures (on a “comply or explain” basis) with regards to sustainability risks and sustainability factors relevant to their investment activities.

    A “sustainability risk”, as defined in the Disclosure Regulation, means an environmental, social or governance event or condition that, if it occurs, could cause a negative material impact on the value of an investment. “Sustainability factors” are environmental, social and employee matters, respect for human rights, anti-corruption and anti-bribery matters.

    Application to UK and Other Non-EU Managers

    Despite the UK’s withdrawal from the EU, both the Disclosure Regulation and Taxonomy Regulation have been added to the list of EU legislation which will be “onshored” by the UK. This means that both regulations will be implemented in the UK and will apply to UK AIFMs, UCITS management companies and portfolio managers authorised under MiFID.

    The Disclosure Regulation covers alternative investment fund managers (as defined in AIFMD)[5] without specifying the territorial scope or status of such AIFMs under AIFMD. The pre-investment disclosure obligations (see below) require AIFMs to include information on ESG considerations in the disclosures mandated under Article 23(1) of AIFMD. Article 23(1) of AIFMD applies to EU/UK managers of EU AIFs (e.g., Irish or Luxembourg structures), as well as managers of non-EU AIFs if they market their funds in the EU/UK under the national private placement regimes through cross-references in Articles 36 and 42 of AIFMD (that establish such regimes). Subject to any further clarifications or guidance which may be published in the future, this could mean that the pre-investment disclosure obligations will apply not only to EU/UK AIFMs who market their EU or non-EU funds, but also to non-EU AIFMs (e.g., US or Swiss investment managers) who market their Cayman and other non-EU funds under Article 42 private placement regimes in the UK or any EU jurisdictions.  

    What Are Managers Expected to Do?

    Asset managers and investment advisers will be required to take the following steps to comply with the Disclosure Regulation:

    • Policies and Procedures. To produce the required disclosures, in-scope firms will need to consider and document the relevance of ESG to their investment policies. In addition, when preparing or updating their staff remuneration policies (including, where required, public or investor disclosures with regards to their remuneration practices), managers will be required to specify how these policies are consistent with the integration of sustainability risks. This will involve making a series of strategic business and investor relations decisions.
    • Website Disclosures. All managers will be required to publish on their websites information about their policies on integration of sustainability risks in their investment decision-making processes. Additional public disclosure obligations will apply to larger firms (with 500 employees or more) and will include descriptions of investment due diligence processes for assessing adverse impacts of investment decisions on sustainability factors, a description of the principal adverse sustainability impacts, policies on their identification and priortisation, any action taken or planned with regards to such sustainability impacts, as well as information on the manager’s shareholder engagement policies. Firms that choose not to take sustainability risks into account when making their investment decisions will be required to provide clear reasons for their decision.
    • Pre-Contractual Disclosures. Disclosures on the manner in which sustainability risks are integrated into investment decisions and advice and the results of the manager’s assessment of the likely impacts of sustainability risks on the returns must also be included in the “pre-contractual disclosures”, such as the investment management agreement relating to a separately managed account, or the private placement memorandum or prospectus of a fund. If a manager does not consider sustainability risks to be relevant, the pre-contractual disclosures must include a clear explanation of the manager’s rationale.
    • Sustainable Investments. Additional detailed disclosure obligations will apply to investments that are marketed as sustainable investments (meeting the requirements of the Taxonomy Regulation) or other products that promote specific ESG characteristics.

    Against the background of an increased investor demand for ESG-related focus, regulators on both sides of the Atlantic are concerned with the adequacy and accuracy of ESG disclosures and the “greenwashing” of financial products, with the SEC’s OCIE already conducting exams reviewing ESG disclosures[6]. Managers should take note of this scrutiny and allow time to formulate ESG policies and practices that are tailored to their businesses and investment approaches ahead of the requirements of the Disclosure Regulation taking effect next year.

    Authored by Anna Maleva-Otto and Joshua B. Wright.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Regulation (EU) 2019/2088, available here.

    [2] Proposal for a Regulation on the Establishment of a Framework to Facilitate Sustainable Investment, latest text available here.

    [3] Draft Commission Delegated Regulation amending Regulation (EU) 2017/565, available here.

    [4] ESMA Technical Advice on Sustainable Finance, available here.

    [5] Legal persons whose regular business is managing one or more alternative investment funds.

    [6] See 2020 Examination Priorities, available here.


    This communication is issued by Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • DEA Initiates Rulemaking to Waive Separate Registration for Mobile NTP

    DEA Initiates Rulemaking to Waive Separate Registration for Mobile NTP

    ARTICLE / CLIENT ALERT

    DEA Initiates Rulemaking to Waive Separate Registration for Mobile NTP

    February 28, 2020

    Read time: 4 min

    Key takeaways
    Overview
    In depth

    On February 26, 2020, the US Drug Enforcement Administration (DEA) issued a Notice of Proposed Rule Making (NPRM), which proposes waiving the requirement of a separate DEA registration at each principal place of business or professional practice where controlled substances are dispensed for narcotic treatment programs (NTP) that utilize a mobile component in the state in which the DEA registrant is registered. The DEA noted that its intent was to make maintenance and detoxification treatments more widely available, especially in rural and underserved communities.

    Under the federal Controlled Substances Act (CSA), a DEA registration is required for each principle place of business or professional practice where controlled substances are manufactured, distributed or dispensed. 21 U.S.C. 822(e)(1). This requirement has posed a challenge to providers such as mobile narcotic treatment programs, whose services—including administering and dispensing controlled substances—logically take place in locations other than the principle place of business.

    Under the proposed rule, an NTP would be allowed to dispense controlled substances is schedules II–V at a location remote from, but within the same state as, the NTP’s registered location for the purpose of maintenance or detoxification treatment regardless of whether dispensing occurred on such a regular basis that the location would constitute a principal place or business or professional practice.

    Although the proposed rule would make operating a mobile component of an NTP a coincident activity of an existing NTP registration, in order to operate the mobile component, the NTP must obtain prior explicit written approval from its local DEA office. The proposed rule also sets forth requirements for security and recordkeeping. Some of these proposed requirements include the following:

    • Persons receiving treatment at a mobile NTP must wait in an area physically separated from the narcotic storage and dispensing area either by a physical entrance (i.e., door or other entryway). If the NTP does not have a separate seating or reception area, patient will need to wait outside of the mobile NTP.
    • When not in use, controlled substances must be stored in a securely locked safe that is bolted or cemented to the floor or wall, equipped with an alarm and not accessible from outside of the mobile NTP.
    • At the end of each day, the mobile NTP must return to the DEA registrant’s location, and all controlled substances must removed from the mobile NTP and secured within the DEA registrant’s location.
    • Records generated during the operations of the mobile component of an NTP must be maintained at the location of the registered NTP and retained for two years.

    In issuing the NPRM, the DEA noted allowing for the operation of mobile NTPs under the conditions specified in the proposed rule would increase access to opioid use treatment with minimal risk of diversion.

    DEA is accepting public comments on the proposed rule until April 27, 2020.

    Authors
    More insights

  • A Re-Examination of the Rules of Property Rights a Post-Petition Gifting in Bankruptcy

    ARTICLE

    A Re-Examination of the Rules of Property Rights a Post-Petition Gifting in Bankruptcy

    February 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • Who Is the General Counsel’s Client? An Important Development

    Who Is the General Counsel’s Client? An Important Development

    ARTICLE

    Who Is the General Counsel’s Client? An Important Development

    February 28, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Joshua David Rogaczewski

    Partner & Deputy General Counsel

    Washington, DC

    More insights

  • Foreign Investment in Qualified Opportunity Zones by Foreign Taxpayers and CFCs

    ARTICLE

    Foreign Investment in Qualified Opportunity Zones by Foreign Taxpayers and CFCs

    February 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • Cross-Border Disputes in the 2020’s

    ARTICLE

    Cross-Border Disputes in the 2020’s

    February 27, 2020

    Read time: 2 min

    Key takeaways
    Overview

    Arne Fuchs and Pauline Walde authored this bylined article “Cross-border disputes in the 2020’s”, featured in Business Law Magazine.

    In depth
    Authors
    More insights

  • U.S. Taxation of “Intangible Income”

    ARTICLE

    U.S. Taxation of “Intangible Income”

    February 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Lowell D. Yoder

    Partner

    Chicago

    More insights

  • FCA Announces Change to the Method for Short Selling Reporting

    FCA Announces Change to the Method for Short Selling Reporting

    ARTICLE / CLIENT ALERT

    FCA Announces Change to the Method for Short Selling Reporting

    February 24, 2020

    Read time: 4 min

    Key takeaways
    Overview

    The UK Financial Conduct Authority (“FCA”) has opened a new portal for reporting net short positions, the Electronic Submission System (“ESS”), with immediate effect. Position holders should note that the FCA no longer accepts notifications by email and should apply to create a new user account with ESS without delay.

    When Should a Net Short Position Be Reported?

    There has been no change with respect to the reporting obligations and the deadline for submission of the notifications under the EU Short Selling Regulation (Regulation 236/2012) (“SSR”). Net short positions in UK-listed shares or UK sovereign debt should be notified to the FCA by 3:30 pm UK time on a T+1 basis. The position should be calculated at midnight on the trading day the position was reached.

    Under the SSR, the requirement to make a private disclosure (to the regulator), in respect of equity positions, applies when a net short position reaches 0.2% of the issued share capital of the company, for each 0.1% increase or decrease thereafter; a final notification must be submitted when the position falls below 0.2%. The public disclosure requirements start at 0.5%. The reporting obligations apply with respect to any shares admitted to trading on a UK or EU trading venue, except shares on the Exempted Shares List maintained by the European Securities and Markets Authority (“ESMA”). The reporting thresholds for sovereign debt are available on ESMA’s website.

    What Has Changed?

    Previously, the FCA required completed notification forms for public or private disclosures to be provided by email. From now, positon holders are required to make notifications through the ESS.  In order to do so, the following steps must be followed:

    1. The position holder (the firm) should first register using the ESS Login Page to create a firm ESS account. Detailed instructions can be found in the newly published ESS User Guide.
    2. Once a position holder’s ESS account has been created and approved by the FCA, each individual who will be making the notification will need to register to make SSR notifications separately, as a reporting person.

    The following documents will be required for each person:

    • Authorisation letter on company letterhead stating that the relevant individual(s) are authorised to submit notifications on behalf of the firm; and
    • Certificate of incorporation of the position holder firm (e.g., the investment manager).

    Authored by Anna Maleva-Otto.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or the author.


    This communication is issued by Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights